Previous Section | Index | Home Page |
10 Mar 2009 : Column 386Wcontinued
Mr. Jamie Reed: To ask the Secretary of State for Health what commercial revenues have been earned by the NHS outside England in each of the last three years; and how they were earned. [261086]
Mr. Bradshaw: The Department does not centrally collect data on commercial revenues earned by the national health service outside England.
Mr. Ancram: To ask the Secretary of State for Health how many legal proceedings have been brought against NHS organisations by private individuals on the basis that public consultations have been improperly conducted in the last five years. [260898]
Ann Keen: The Department does not collect such information, and there is no requirement on national health service bodies to inform the Department when legal proceedings are brought against them.
Mr. Lansley: To ask the Secretary of State for Health what the estimated cost is of establishing the Centre of Excellence referred to in paragraph 117 of A High Quality Workforce: NHS Next Stage Review. [260889]
Ann Keen: The cost of the Centre of Excellence is not yet established. Since the publication of A High Quality Workforce we have taken the time to consult with stakeholders across health, social care and education on what is an important strategic investment for the whole workforce planning system. The feedback received is feeding into the design of the business case and specification for the Centre of Excellence. This will be completed soon, with procurement scheduled to commence in the spring.
Mr. Lansley: To ask the Secretary of State for Health how many nurses were enrolled in a foundation period of preceptorship in each year for which the figures are available; and what the budget was for such preceptorships in each year. [260845]
Ann Keen:
Neither the number of nurses undertaking preceptorship or the amount spent is held centrally. The Government recognise the value of preceptorship and have made £10 million available in 2008-09 for strategic health authorities to invest in preceptorship. We plan to
increase this to £20 million in 2009-10 and £30 million in 2010-11 and each subsequent year.
Mr. Lansley: To ask the Secretary of State for Health how many occupational therapists worked in the NHS in each year since 1997; and how many worked in each NHS organisation in each of the last three years. [260847]
Ann Keen: A table showing the number of qualified occupational therapists employed in the national health service in the years requested has been placed in the Library.
Sandra Gidley: To ask the Secretary of State for Health how many children were born with an alcohol dependency in each of the last three years. [261551]
Dawn Primarolo: The information requested is not collected centrally.
Mr. Amess: To ask the Secretary of State for Health how many women of each age group in each region after taking mifepristone were subject to (a) excessive bleeding, (b) haemorrhaging when the foetus was expelled from the uterus, (c) damage to the cervix and (d) an infection in each of the last five years for which figures are available, broken down by length of gestation of the pregnancy. [261578]
Dawn Primarolo: The information is shown in the following table.
Total complications reported( 1) for abortions using Mifepristone (Mifegyne, RU486) by gestation and age, residents, England, 2003 to 2007 | |||||
Haemorrhage | Other complications( 2) | ||||
Total abortions using RU486 | Total complications | Gestation under 13 weeks | 13 weeks + | All gestations | |
Haemorrhage | Other complications( 2) | ||||
Total abortions using RU48 | Total complications | Age under 25 years | 25 years+ | All ages | |
(1) Up until the time of discharge from the place of termination. (2 )Includes uterine perforation and/or sepsis. Note: Breakdown by region is not possible due to small numbers. This is line with the Office for National Statistics guidance on the disclosure of abortion statistics (2005) |
Mr. Burns: To ask the Secretary of State for Health how many people under 25 years received treatment for each sexually transmitted infection in (a) West Chelmsford constituency and (b) Essex in each of the last 10 years. [261769]
Dawn Primarolo:
Data are only available on the number of diagnoses of sexually transmitted infections (STIs)
in genitourinary medicine (GUM) clinics and only available by strategic health authority (SHA). The following table gives the number of diagnoses for five selected STT
diagnoses in patients under 25 in the East of England SHA between 1998 and 2007, the latest year for which data are available.
STI diagnoses | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 |
Notes: 1. Data by age-group are only available for five selected STI diagnoses (Chlamydia, gonorrhoea, genital warts, genital herpes and primary and secondary syphilis) 2. The data available from the KC60 statutory returns are for diagnoses made in GUM clinics only. Diagnoses made in other clinical settings, such as general practice, are not recorded in the KC60 dataset. 3. The data available from the KC60 statutory returns are the number of diagnoses made, not the number of patients diagnosed. 4. The information provided has been adjusted for missing clinic data. 5. Data on S71 diagnoses are provided. Data on treatment received are unavailable. Source: Health Protection Agency, KC60 returns |
In addition to STTs diagnosed in a GUM clinic, the National Chlamydia Screening programme (NCSP) provides chlamydia screening to asymptomatic people under the age of 25 years of age in England. The NCSP was launched in 2003 when a phased implementation programme started. The following table shows the number of diagnoses of chlamydia in patients between the ages of 13-24 years between April 2003 and December 2008 in Mid Essex primary care trust (PCT), Essex (which includes Mid Essex PCT, North East Essex PCT, South East Essex PCT and West Essex PCT) and The East of England SHA.
Area | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 |
(1) Cell size of one to four has been masked to protect deductive disclosure in accordance with Office for National Statistics guidelines. Notes: 1. Data on Chlamydia diagnoses are provided. Complete data on treatment received are unavailable. 2. The figure for Essex represents the sum of Chlamydia diagnoses made in Mid Essex, North East Essex, South East Essex and West Essex PCTs. 3. South East Essex is a phase 1 programme area which started screening in 2003-04. Mid Essex, North East Essex and West Essex are all phase three programme areas which started screening in 2006-07. 4. NSCP data are presented by PCT of residence. 5. The data available from the NCSP are the number of diagnoses made and not the number of patients diagnosed. Source: NCSP |
Stephen Williams: To ask the Secretary of State for Health what assessment he has made of the effectiveness of the smoking ban in reducing levels of smoking in England. [261860]
Dawn Primarolo: Smoke free legislation was introduced primarily to protect people from the harm of second hand smoke in enclosed parts of work and public places.
On 1 July 2008 the Department published the report Smokefree Englandone year on, which gives details of the impact of the smoke free law in its first year. A copy of the Smokefree Englandone year on report has already been placed in the Library.
Research has been commissioned by the Department, which will evaluate various aspects of the impact of the smoke free law in England. The resulting reports will be published once completed and peer reviewed.
In a report in July 2008, Professor Robert West Cancer Research UKs director of tobacco studies based at University College London, presented findings from the Smokers Toolkit Study that shows smoke free legislation in England has helped more smokers to quit than ever before and will continue in preventing an estimated 40,000 premature deaths over the next 10 years.
Next Section | Index | Home Page |